Frontiers in Genetics,
Journal Year:
2021,
Volume and Issue:
12
Published: Sept. 27, 2021
Cells
must
replicate
and
segregate
their
DNA
to
daughter
cells
accurately
maintain
genome
stability
prevent
cancer.
replication
is
usually
fast
accurate,
with
intrinsic
(proofreading)
extrinsic
(mismatch
repair)
error-correction
systems.
However,
forks
slow
or
stop
when
they
encounter
lesions,
natural
pause
sites,
difficult-to-replicate
sequences,
are
treated
polymerase
inhibitors
hydroxyurea,
which
depletes
nucleotide
pools.
These
challenges
termed
stress,
respond
by
activating
damage
response
signaling
pathways
that
delay
cell
cycle
progression,
stimulate
repair
fork
restart,
induce
apoptosis.
Stressed
managed
rescue
from
adjacent
forks,
repriming,
translesion
synthesis,
template
switching,
reversal
produces
a
single-ended
double-strand
break
(seDSB).
also
collapse
seDSBs
single-strand
nicks
cleaved
structure-specific
nucleases.
Reversed
can
be
restarted
homologous
recombination
(HR),
but
pose
risks
of
mis-rejoining
non-homologous
end-joining
(NHEJ)
other
DSBs,
causing
rearrangements.
HR
requires
resection
broken
ends
create
3’
single-stranded
for
RAD51
recombinase
loading,
resected
refractory
NHEJ.
This
Mini
Review
highlights
mechanisms
help
promoting
accurate
restart
HR.
NAR Cancer,
Journal Year:
2023,
Volume and Issue:
5(1)
Published: Jan. 11, 2023
Abstract
DNA
damage
tolerance
and
mutagenesis
are
hallmarks
enabling
characteristics
of
neoplastic
cells
that
drive
tumorigenesis
allow
cancer
to
resist
therapy.
The
‘Y-family’
trans-lesion
synthesis
(TLS)
polymerases
enable
replicate
damaged
genomes,
thereby
conferring
tolerance.
Moreover,
Y-family
inherently
error-prone
cause
mutations.
Therefore,
TLS
potential
mediators
important
tumorigenic
phenotypes.
skin
cancer-propensity
syndrome
xeroderma
pigmentosum-variant
(XPV)
results
from
defects
in
the
Polymerase
Pol
eta
(Polη)
compensatory
deployment
alternative
inappropriate
polymerases.
However,
extent
which
dysregulated
contributes
underlying
etiology
other
human
cancers
is
unclear.
Here
we
consider
broad
impact
on
We
survey
ways
pathologically
altered
cancer.
summarize
evidence
shape
review
studies
implicating
as
a
driver
carcinogenesis.
Because
many
treatment
regimens
comprise
DNA-damaging
agents,
pharmacological
inhibition
an
attractive
strategy
for
sensitizing
tumors
genotoxic
therapies.
discuss
tractability
pathway
recent
progress
development
inhibitors
therapeutic
purposes.
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(3)
Published: Jan. 19, 2024
Mutation
signatures
associated
with
apolipoprotein
B
mRNA
editing
catalytic
polypeptide-like
3A/B
(APOBEC3A/B)
cytidine
deaminases
are
prevalent
across
cancers,
implying
their
roles
as
mutagenic
drivers
during
tumorigenesis
and
tumor
evolution.
APOBEC3A
(A3A)
expression
induces
DNA
replication
stress
increases
the
cellular
dependency
on
ataxia
telangiectasia
Rad3-related
(ATR)
kinase
for
survival.
Nonetheless,
how
A3A
remains
unclear.
We
show
that
without
slowing
forks.
find
single-stranded
(ssDNA)
gaps
through
PrimPol-mediated
repriming.
A3A-induced
ssDNA
repaired
by
multiple
pathways
involving
ATR,
RAD51,
translesion
synthesis.
Both
ATR
inhibition
trapping
of
poly(ADP-ribose)
polymerase
(PARP)
PARP
inhibitor
impair
repair
gaps,
preferentially
killing
A3A-expressing
cells.
When
used
in
combination,
inhibitors
selectively
kill
cells
synergistically
a
manner
dependent
PrimPol-generated
gaps.
Thus,
arises
from
which
confer
therapeutic
vulnerability
to
gap-targeted
inhibitors.
Annual Review of Genetics,
Journal Year:
2023,
Volume and Issue:
57(1), P. 157 - 179
Published: Aug. 8, 2023
Transcription
and
replication
both
require
large
macromolecular
complexes
to
act
on
a
DNA
template,
yet
these
machineries
cannot
simultaneously
the
same
sequence.
Conflicts
between
transcription
(transcription–replication
conflicts,
or
TRCs)
are
widespread
in
prokaryotes
eukaryotes
have
capacity
cause
damage
compromise
complete,
faithful
of
genome.
This
review
will
highlight
recent
studies
investigating
genomic
locations
TRCs
mechanisms
by
which
they
may
be
prevented,
mitigated,
resolved.
We
address
work
from
model
organisms
mammalian
systems
but
predominantly
focus
multicellular
owing
additional
complexities
inherent
coordination
context
cell
type–specific
gene
expression
higher-order
chromatin
organization.
Cancer Science,
Journal Year:
2023,
Volume and Issue:
114(7), P. 2709 - 2721
Published: May 15, 2023
DNA
replication
stress
(RS)
causes
genomic
instability
and
vulnerability
in
cancer
cells.
To
counteract
RS,
cells
have
evolved
various
mechanisms
involving
the
ATR
kinase
signaling
pathway,
which
regulates
origin
firing,
cell
cycle
checkpoints,
fork
stabilization
to
secure
fidelity
of
replication.
However,
also
alleviates
RS
support
survival
by
driving
tolerance,
thereby
contributing
therapeutic
resistance.
Cancer
harboring
genetic
mutations
other
changes
that
disrupt
normal
increase
risk
damage
levels
conferring
addiction
activity
for
sustainable
susceptibility
approaches
using
inhibitors
(ATRis).
Therefore,
clinical
trials
are
currently
being
conducted
evaluate
efficacy
ATRis
as
monotherapies
or
combination
with
drugs
biomarkers.
In
this
review,
we
discuss
recent
advances
elucidation
functions
response
its
relevance
when
utilizing
ATRis.
Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(5), P. 2340 - 2354
Published: Jan. 5, 2024
DNA
replication
stress-induced
fork
arrest
represents
a
significant
threat
to
genomic
integrity.
One
major
mechanism
of
restart
involves
repriming
downstream
the
arrested
by
PRIMPOL,
leaving
behind
single-stranded
(ssDNA)
gap.
Accumulation
nascent
strand
ssDNA
gaps
has
emerged
as
possible
determinant
cellular
hypersensitivity
genotoxic
agents
in
certain
genetic
backgrounds
such
BRCA
deficiency,
but
how
are
converted
into
cytotoxic
structures
is
still
unclear.
Here,
we
investigate
processing
PRIMPOL-dependent
upon
stress
induced
hydroxyurea
and
cisplatin.
We
show
that
generated
PRIMPOL-overexpressing
cells
expanded
3'-5'
direction
MRE11
exonuclease,
5'-3'
EXO1
exonuclease.
This
bidirectional
exonucleolytic
gap
expansion
ultimately
promotes
their
conversion
DSBs.
moreover
identify
de-ubiquitinating
enzyme
USP1
critical
regulator
PRIMPOL-generated
gaps.
accumulation
during
S-phase,
nucleases.
activity
linked
its
role
PCNA,
suggesting
PCNA
ubiquitination
prevents
replication.
Finally,
depletion
suppresses
DSB
formation
cells,
highlighting
an
unexpected
for
promoting
instability
under
these
conditions.